Novo nordisk tests new obesity drug in early human trial
NCT ID NCT07437079
Summary
This early-stage study is testing whether a new experimental drug called NNC6989-0001 is safe for people with overweight or obesity. The trial will enroll 96 healthy adults to receive either the drug or a placebo, with researchers carefully monitoring for side effects. This is the first time this medication is being tested in humans, so the main goal is to understand how the body processes it and what side effects might occur.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON Early Phase Services, LLC
RECRUITINGLenexa, Kansas, 66219, United States
Conditions
Explore the condition pages connected to this study.